What does this research mean for the field?

Immunocompromised children do not have an increased risk of SARS-CoV-2 infection but experience higher hospitalization rates, which likely reflects precautionary clinical management rather than increased disease severity. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to assess the risk of SARS-CoV-2 infection and hospitalization among immunocompromised children.

March 25, 2026Open Access

Risk of SARS ‐ CoV ‐2 Infection and Hospitalisation in Immunocompromised Children: A Population‐Based Cohort Study in Italy and Norway

Puntos clave

This research aims to assess the risk of SARS-CoV-2 infection and hospitalization among immunocompromised children.
Conducted a population-based cohort study
Analyzed infection and hospitalisation rates in immunocompromised children
Compared findings between Italy and Norway
No increased risk of SARS-CoV-2 infection in immunocompromised children
Higher hospitalisation rates observed despite low severe disease incidence
Findings suggest that cautious clinical management plays a role

Resumen

IC did not have an increased risk of infection but experienced higher hospitalisation rates despite a low incidence of severe disease. This pattern may reflect precautionary clinical management rather than increased disease severity.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo